Key learnings from the INBUILD trial in patients with progressive pulmonary fibrosis
In a patient with interstitial lung disease (ILD) of known or unknown etiology other than idiopathic pulmonary fibrosis (IPF), progressive pulmonary fibrosis (PPF) is defined by worsening lung fibrosis on high-resolution computed tomography (HRCT), decline in lung function, and/or deterioration in s...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
SAGE Publishing
2024-08-01
|
| Seri Bilgileri: | Therapeutic Advances in Respiratory Disease |
| Online Erişim: | https://doi.org/10.1177/17534666241266343 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|